AzTrials
AzTrials

DeliriumHOPESNCT02863081

Helping Older Persons Emerge Stronger

An observational study of Delirium and Ventilators, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Select Specialty, a national network of more than 100 LTACHs across the United States, has expressed the desire to adopt the ABCDEF bundle as a "standard of care" for its patients. As part of this initiative, Select first plans to conduct an ABCDEF bundle quality improvement project in one of its local hospitals. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Delirium, Ventilators, Pain
What is being tested?
Survey and interview
How many people
6 participants
Where
1 siteUnited States
Study dates
Jul 2016to 1 Jul 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: 1. Healthcare providers working in a LTACH 2. Chronically critically ill patients requiring mechanical ventilation at the time of LTACH admission

Who may be able to join

  • >18 years old
  • Admitted to the LTACH with a tracheostomy
  • Require mechanical ventilation > 8 hours a day upon LTACH admission
  • English speaking

Who cannot join

  • None
  • Aims 2 and 3:
  • Severe neurologic deficits defined as coma (i.e., Richmond Agitation Sedation Score < -4 or -5 due to stroke, intracranial hemorrhage, cranial trauma, malignancy, anoxic brain injury, or cerebral edema)
  • Inability to obtain informed consent from the patient's legally authorized representative (LAR) within 72 hours of meeting all inclusion criteria
  • Chronic ventilator dependence that is deemed "not weanable" by admitting LTACH physician.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University College of Nursing

    Columbus, Ohio, 43210

Other trials in United States

About this study

Official title: Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission

Select Specialty, a national network of more than 100 LTACHs across the United States, has expressed the desire to adopt the ABCDEF bundle as a "standard of care" for its patients. As part of this initiative, Select first plans to conduct an ABCDEF bundle quality improvement project in one of its local hospitals. The overall purpose of this before-after study is to study prospectively the process and effects of implementing the ABCDEF bundle into the everyday care of patients requiring prolonged mechanical ventilation in the LTACH setting.

Read the detailed description

The 300,000 chronically critically ill patients each year who require prolonged mechanical ventilation (PMV)1,2 represent an ever-growing, extremely vulnerable, proportion of intensive care unit (ICU) survivors.3 The increasing number of these patients is an important factor in the expanded use of long-term acute care hospitals (LTACHs), centers that specialize in mechanical ventilation weaning and rehabilitation. The 412 LTACHs currently operated in the United States admit more than 130,000 patients annually and account for more than $5 billion in Medicare expenditures each year.4,5 Unfortunately, LTACH stays for patients requiring PMV are typically complicated and associated with a number of poor outcomes including very high one-year mortality rates (44-77%),6,7 severe and enduring brain dysfunction (i.e., coma and/or delirium), life-altering functional decline, substantial pain and suffering, caregiver burden and diminished quality of life.6-11 While returning home is often an important goal for patients and their families,3 this is a rare outcome in this population.11 Rather, patients requiring PMV often experience multiple transitions in care in the year following their original hospital admission (median of 4), which results in further costs and persistent, profound disability.9 Despite these disheartening findings, to date there is very limited scientific evidence available to help clinicians care for the chronically critically ill, particularly those requiring PMV in LTACHs.

Chronically critically ill patients are generally older, sicker and have more comorbidities than their acutely ill counterparts.12 Importantly, they also suffer from much greater symptom burden, with up to 90% of patients experiencing at least one distressing symptom during the course of their illness (e.g., pain, dyspnea, weakness).13 While these symptoms are often thought of as unfortunate and inevitable consequences of critical illness,14 evidence suggests that the inappropriate management of these symptoms may actually be causal to the poor outcomes experienced by this group.15 For example, the results of numerous, well-designed, clinical trials conducted in the traditional ICU setting by our team and others suggest regular pain, agitation, and delirium assessment, prevention and treatment, coupled with strategies that decrease patients' exposure to sedative medications, support early mobilization, promote evidence-based mechanical ventilation discontinuation approaches, and actively engage and empower family members in patient care can positively affect important patient-centered outcomes (e.g., improved survival and physical/cognitive ability).16-26 One unifying method of implementing these evidence based interventions into everyday practice is consistent and reliable use of the ABCDEF bundle (i.e., Assess, prevent, and manage pain, Both Spontaneous Awakening Trials (SATs) \& Spontaneous Breathing Trials (SBTs), Choice of analgesia and sedation, Delirium assess, prevent, and manage, Early mobility and exercise, and Family engagement and empowerment).27 Congruent with the Society of Critical Care Medicine's Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium and endorsed by a number of patient safety and quality organizations including the Institute for Healthcare Improvement and the Gordon and Betty Moore Foundation, the ABCDEF bundle is being actively implemented in ICUs throughout the world. The strength of evidence supporting the ABCDEF bundle, coupled with this strong implementation momentum, has prompted interest in the LTACH in applying the bundle into the everyday care of chronically critically ill patients who require mechanical ventilation.

Select Specialty, a national network of more than 100 LTACHs across the United States, has expressed the desire to adopt the ABCDEF bundle as a "standard of care" for its patients. As part of this initiative, Select first plans to conduct an ABCDEF bundle quality improvement project in one of its local hospitals. The overall purpose of this before-after study is to study prospectively the process and effects of implementing the ABCDEF bundle into the everyday care of patients requiring prolonged mechanical ventilation in the LTACH setting. Specifically the study's aims are to:

Aim 1: Identify facilitators and barriers to successful ABCDEF bundle implementation in the LTACH setting.

Aim 2: Compare the symptom experience (e.g., pain, agitation, anxiety, fatigue, shortness of breath, restlessness, sadness, hunger, fear, thirst, confusion sedative medication exposure) of patients receiving usual LTACH care (during months 1-4.5) to those treated with the ABCDEF bundle (during months 4.5-9).

Aim 3. Evaluate the impact ABCDEF bundle implementation has on safety (i.e., new pneumonias, device self-removal) and patient-centered outcomes (i.e., delirium/coma free days, weaning duration, tracheostomy removal , mortality, depression, post-traumatic stress disorder, functional and cognitive ability, discharge disposition, opioid and benzodiazepine withdrawal rates, and quality of life) of patients receiving usual LTACH care (during months 1-4.5) to those treated with the ABCDEF bundle (during months 4.5-9).

To complete these aims the investigators will administer an on-line survey and conduct focus group interviews with LTACH staff before and after the ABCDEF bundle is implemented into everyday care. Over the course of a nine month period, the investigators will also consent and enroll 81 patients who require mechanical ventilation at the time of LTACH admission. These patients will undergo daily, in-person symptom assessment using valid and reliable screening tools. Finally, medical record reviews and brief patient interviews will be conducted to obtain data on our outcomes of interest.

Being tested
Survey, interview
Medical subject headings
Delirium, Pain, Psychomotor Agitation, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SurveyOther

    Also called Focus group interviews

    Administered to healthcare providers

  • interviewOther

    Also called symptom assessment, Medical record review

    Administered to patients and LAR (i.e., interviews)

Study groups in NCT02863081
Study groupRoleWhat they receive
Healthcare providersAll healthcare providers working in the participating LTACH will be asked to complete 2 surveys and invited to participate in focus group meetings
Receives: Other: Survey; Other: interview
Patients81 LTACH patients will be enrolled over the course of a 9 month period. Each patient and their LAR will be interviewed at the time of LTACH admission to garner information about their pre hospitalization physical, functional, and cognitive health status. Each day enrolled patients will undergo daily symptom assessments and medical record reviews. At the time of LTACH discharge all enrolled patients will be interviewed again to garner information about their discharge physical, functional, and cognitive health status.
Receives: Other: interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Facilitators/Barriers to successful ABCDEF bundle implementation in the LTACH setting

    Achieved through surveys and focus groups of LTACH providers

    Measured: 9 months

  2. Pain

    As measured by numeric rating scale of behavioral pain sclae

    Measured: 9 months

  3. All cause mortality

    Measured: 9 months

Secondary outcomes (16)
  1. Level of Arousal

    As measured by Richmond Agitation and Sedation Scale (RASS)

    Measured: 9 months

  2. Delirium

    As measured by Confusion Assessment Method ICU (CAM-ICU)

    Measured: 9 months

  3. Anxiety Anxiety

    As measured by Visual Analog Scale

    Measured: 9 months

  4. Other Symptoms

    As measured by Patient Symptom Survey

    Measured: 9 month

  5. Opioid Withdrawal

    As measured by Clinical Opiate WIthdrawl Scale

    Measured: 9 months

  6. Benzodiazepine Withdrawal

    As measured by Clinical Institute Withdrawal Assessment Scale-Benzodiazepines

    Measured: 9 months

  7. Delirium/Coma free days

    As measured by CAM ICU and RASS

    Measured: 9 months

  8. Weaning duration

    Measured: 9 months

  9. New Pneumonia

    Measured: 9 months

  10. Device self-removal

    Measured: 9 months

  11. Tracheostomy removal

    Measured: 90 months

  12. Depression

    As measured by Hospital Anxiety and Depression Scale

    Measured: 90 months

  13. Post Traumatic Stress Disorder

    As measured by Impact of Event Scale

    Measured: 9 months

  14. Functional ability

    As measured by Functional Status Score ICU, KATZ ADL, LAWTON IADL

    Measured: 9 months

  15. Cognitive ability

    As measure by Mini Mental State Exam

    Measured: 9 months

  16. Quality of Life

    As measured by SF 36

    Measured: 9 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2016 (estimated)
  2. Study startJul 2016
  3. Primary completion1 Jul 2017
  4. Study completion1 Jul 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02863081
Sponsor's protocol ID
2016H0001
Acronym
HOPES
Status last verified
Sep 2017
First submitted
4 Aug 2016
Last updated
19 Sep 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Delirium and Ventilators, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Facilitators/Barriers to successful ABCDEF bundle implementation in the LTACH setting (time frame: 9 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in